Classification
- Anatomical main groupVVarious
- Therapeutic subgroupV08
- Pharmacological subgroupV08A
- Chemical subgroupV08AB
- Chemical substanceV08AB02Iohexol
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Serbia
ALIMS · 12 registrations
Show all 12United States
FDA · 11 registrations
- Omnipaque 122.6% · solution · Ge Healthcare
- Omnipaque 14030.2% · injectable · Ge Healthcare
- Omnipaque 18038.8% · solution · Ge Healthcare
- Omnipaque 24051.8% · solution · Ge Healthcare
Netherlands
CBG-MEB · 8 registrations
At a glance
- ATC code
- V08AB02
- ATC group
- Various
- Registers
- 9
- Historical lists
- 2
- Registrations
- 75
- With their own page
- 51
- Companies
- 16
All medicines with Iohexol
Human medicines from every register that match Iohexol by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
79 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Iohexol | United States | 64.7% | solution | Marketed | Amneal |
| Iohexol iMAX | Serbia | 755mg/mL | rastvor za injekciju | Authorised | Peyton Medical D.O.O. |
| Iohexol iMAX | Serbia | 755mg/mL | rastvor za injekciju | Authorised | Peyton Medical D.O.O. |
| Iohexol iMAX | Serbia | 755mg/mL | rastvor za injekciju | Authorised | Peyton Medical D.O.O. |
| Iohexol iMAX | Serbia | 755mg/mL | rastvor za injekciju | Authorised | Peyton Medical D.O.O. |
| Iohexol iMAX | Serbia | 755mg/mL | rastvor za injekciju | Authorised | Peyton Medical D.O.O. |
| Iohexol iMAX | Serbia | 755mg/mL | rastvor za injekciju | Authorised | Peyton Medical D.O.O. |
| Iohexol ADOH 350 mg I/ml oplossing voor injectie | Netherlands | Oplossing voor injectie | Authorised | Adoh B.V. | |
| Iohexol ICG farma 647 mg/ml (300 mg jodium/ml), oplossing voor injectie | Netherlands | Oplossing voor injectie | Authorised | UAB ICG Farma | |
| Iohexol ICG farma 755 mg/ml (350 mg jodium/ml), oplossing voor injectie | Netherlands | Oplossing voor injectie | Authorised | UAB ICG Farma | |
| Omnipaque 12 | United States | 2.6% | solution | Marketed | Ge Healthcare |
| Omnipaque 140 | United States | 30.2% | injectable | Marketed | Ge Healthcare |
| Omnipaque 180 | United States | 38.8% | solution | Marketed | Ge Healthcare |
| Omnipaque 240 | United States | 51.8% | solution | Marketed | Ge Healthcare |
| Omnipaque 300 | United States | 64.7% | solution | Marketed | Ge Healthcare |
| Omnipaque 350 | United States | 75.5% | solution | Marketed | Ge Healthcare |
| Omnipaque 9 | United States | 1.9% | solution | Marketed | Ge Healthcare |
| Omnipaque 210 | United States | 45.3% | injectable | Not marketed | Ge Healthcare |
| Omnipaque 70 | United States | 15.1% | solution | Not marketed | Ge Healthcare |
| Oraltag | United States | 9.7GM/BOT | for solution | Not marketed | Interpharma Praha As |
| OMNIPAQUE 240 mg Iodo /ml SOLUCION INYECTABLE | Spain | 518 mg | solución inyectable | Marketed | Ge Healthcare Bio-Sciences, S.A.U. |
| OMNIPAQUE 300 mg Iodo /ml SOLUCION INYECTABLE | Spain | 647 mg | solución inyectable | Marketed | Ge Healthcare Bio-Sciences, S.A.U. |
| OMNIPAQUE 350 mg Iodo /ml SOLUCION INYECTABLE | Spain | 755 mg | solución inyectable | Marketed | Ge Healthcare Bio-Sciences, S.A.U. |
| Omnipaque 140 mg I/ml, injectievloeistof | Netherlands | Oplossing voor injectie | Authorised | GE Healthcare B.V. | |
| Omnipaque 180 mg I/ml, injectievloeistofCombination | Netherlands | Oplossing voor injectie | Authorised | GE Healthcare B.V. |